Science Current Events | Science News | Brightsurf.com
 

Business Wire : OXiGENE's Lead Compound CA4P Enhances the Anti-Tumor Activity of Avastin in Pre-clinical Studies. | Digital

by Business Wire (Publisher)

List Price: $5.95  
Available:  Available for download now

Binding:  Digital
Publisher:  Business Wire
Page Count:  3 Pages
Sales Rank:  7,453,609th
© 2009 BrightSurf.com